Back to Search Start Over

451PD Osimertinib at 80 mg for refractory leptomeningeal metastases in T790M-positive EGFR-mutant non-small cell lung cancer

Authors :
A. Hata
S. Nanjo
C. Okuda
R. Kaji
K. Masago
S. Fujita
K. Irie
H. Okada
S. Fukushima
N. Katakami
Source :
Annals of Oncology. 27
Publication Year :
2016
Publisher :
Elsevier BV, 2016.

Subjects

Subjects :
Oncology
Hematology

Details

ISSN :
15698041 and 09237534
Volume :
27
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........1e46ecddabab60a220831aa6fe13b893
Full Text :
https://doi.org/10.1093/annonc/mdw594.015
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details